Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 76.68 CHF 1.03% Market Closed
Market Cap: 38.1B CHF
Have any thoughts about
Alcon AG?
Write Note

Intrinsic Value

The intrinsic value of one ALC stock under the Base Case scenario is 73.08 CHF. Compared to the current market price of 76.68 CHF, Alcon AG is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALC Intrinsic Value
73.08 CHF
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Alcon AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALC?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Alcon AG

Provide an overview of the primary business activities
of Alcon AG.

What unique competitive advantages
does Alcon AG hold over its rivals?

What risks and challenges
does Alcon AG face in the near future?

Has there been any significant insider trading activity
in Alcon AG recently?

Summarize the latest earnings call
of Alcon AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Alcon AG.

Provide P/S
for Alcon AG.

Provide P/E
for Alcon AG.

Provide P/OCF
for Alcon AG.

Provide P/FCFE
for Alcon AG.

Provide P/B
for Alcon AG.

Provide EV/S
for Alcon AG.

Provide EV/GP
for Alcon AG.

Provide EV/EBITDA
for Alcon AG.

Provide EV/EBIT
for Alcon AG.

Provide EV/OCF
for Alcon AG.

Provide EV/FCFF
for Alcon AG.

Provide EV/IC
for Alcon AG.

Show me price targets
for Alcon AG made by professional analysts.

What are the Revenue projections
for Alcon AG?

How accurate were the past Revenue estimates
for Alcon AG?

What are the Net Income projections
for Alcon AG?

How accurate were the past Net Income estimates
for Alcon AG?

What are the EPS projections
for Alcon AG?

How accurate were the past EPS estimates
for Alcon AG?

What are the EBIT projections
for Alcon AG?

How accurate were the past EBIT estimates
for Alcon AG?

Compare the revenue forecasts
for Alcon AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Alcon AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Alcon AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Alcon AG compared to its peers.

Compare the P/E ratios
of Alcon AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Alcon AG with its peers.

Analyze the financial leverage
of Alcon AG compared to its main competitors.

Show all profitability ratios
for Alcon AG.

Provide ROE
for Alcon AG.

Provide ROA
for Alcon AG.

Provide ROIC
for Alcon AG.

Provide ROCE
for Alcon AG.

Provide Gross Margin
for Alcon AG.

Provide Operating Margin
for Alcon AG.

Provide Net Margin
for Alcon AG.

Provide FCF Margin
for Alcon AG.

Show all solvency ratios
for Alcon AG.

Provide D/E Ratio
for Alcon AG.

Provide D/A Ratio
for Alcon AG.

Provide Interest Coverage Ratio
for Alcon AG.

Provide Altman Z-Score Ratio
for Alcon AG.

Provide Quick Ratio
for Alcon AG.

Provide Current Ratio
for Alcon AG.

Provide Cash Ratio
for Alcon AG.

What is the historical Revenue growth
over the last 5 years for Alcon AG?

What is the historical Net Income growth
over the last 5 years for Alcon AG?

What is the current Free Cash Flow
of Alcon AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Alcon AG.

Business Breakdown

Alcon AG, a leader in the global eye care industry, is dedicated to enhancing the quality of life for patients through innovative solutions and cutting-edge technologies. Formed in 1945, the company specializes in developing, manufacturing, and marketing surgical and vision care products that cater to a wide range of eye-related conditions. With a robust portfolio that includes advanced cataract surgery instruments, contact lenses, and dry eye treatments, Alcon has positioned itself as a formidable player in both the surgical and non-surgical segments of the market. The company's commitment to research and development ensures a steady stream of innovations, attracting a loyal customer base a...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alcon AG

Current Assets 6.3B
Cash & Short-Term Investments 1.7B
Receivables 1.8B
Other Current Assets 2.8B
Non-Current Assets 24B
Long-Term Investments 705m
PP&E 4.8B
Intangibles 17.7B
Other Non-Current Assets 840m
Current Liabilities 2.5B
Accounts Payable 849m
Short-Term Debt 10m
Other Current Liabilities 1.6B
Non-Current Liabilities 6.5B
Long-Term Debt 4.9B
Other Non-Current Liabilities 1.6B
Efficiency

Earnings Waterfall
Alcon AG

Revenue
9.8B USD
Cost of Revenue
-4.3B USD
Gross Profit
5.4B USD
Operating Expenses
-4.1B USD
Operating Income
1.3B USD
Other Expenses
-154m USD
Net Income
1.2B USD

Free Cash Flow Analysis
Alcon AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Alcon generated $2.4 billion in sales, marking a 6% increase, with core earnings per share rising 25% to $0.81. The company reported strong free cash flow of $1.3 billion year-to-date, its highest ever. A notable product launch, the Precision7 contact lens, is set for January 2025. For 2024, Alcon has updated its revenue guidance to $9.8 to $9.9 billion, projecting a constant currency growth rate of 6% to 7%. However, operating margin guidance has been tightened to 20.5% to 21%, reflecting investment in new product launches and inventory pressures.

What is Earnings Call?
Fundamental Scores

ALC Profitability Score
Profitability Due Diligence

Alcon AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
51/100
Profitability
Score

Alcon AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

ALC Solvency Score
Solvency Due Diligence

Alcon AG's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
65/100
Solvency
Score

Alcon AG's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALC Price Targets Summary
Alcon AG

Wall Street analysts forecast ALC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALC is 91.57 CHF with a low forecast of 80.72 CHF and a high forecast of 108.15 CHF.

Lowest
Price Target
80.72 CHF
5% Upside
Average
Price Target
91.57 CHF
19% Upside
Highest
Price Target
108.15 CHF
41% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALC?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ALC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ALC News

Other Videos

Profile

Alcon AG Logo
Alcon AG

Country

Switzerland

Industry

Health Care

Market Cap

37.9B CHF

Dividend Yield

0.31%

Description

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 24,389 full-time employees. The company went IPO on 2019-04-09. The firm operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The firm also offers continuing education for eye care professionals.

Contact

FRIBOURG
Fribourg
Rue Louis-d'Affry 6
www.alcon.com

IPO

2019-04-09

Employees

24 389

Officers

Executive Chairman
Mr. F. Michael Ball
CEO & Director
Mr. David J. Endicott
Executive Director
Mr. Arthur B. Cummings M.D.
Chief Financial Officer
Mr. Timothy C. Stonesifer
Senior VP & COO
Mr. Ian Bell
Chief Accounting Officer
Margaret Buckley
Show More
Senior VP, Head of Global R&D and Chief Scientific Officer
Dr. Franck Leveiller
Senior VP, General Counsel & Corporate Secretary
Mr. Royce R. Bedward
Senior VP, Chief HR Officer & Corporate Communications
Ms. Kimberly Martin
Head of Corporate Development, Strategy, BD&L and M&A
Mr. Laurent Attias
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALC stock?

The intrinsic value of one ALC stock under the Base Case scenario is 73.08 CHF.

Is ALC stock undervalued or overvalued?

Compared to the current market price of 76.68 CHF, Alcon AG is Overvalued by 5%.

Back to Top